A1210000

Antazoline hydrochloride

European Pharmacopoeia (EP) Reference Standard

• 別名: 2-(N-Benzylanilinomethyl)-2-imidazoline hydrochloride
• 実験式（ヒル表記法）: C₁₇H₁₉N₃ · HCl
• CAS番号: 2508-72-7
• 分子量: 301.81
• MDL番号: MFCD00058145
• UNSPSCコード: 41116107
• PubChem Substance ID: 329770687
• NACRES: NA.24

特性

• グレード: pharmaceutical primary standard
• APIファミリー: antazoline
• メーカー／製品名: EDQM
• アプリケーション: pharmaceutical (small molecule)
• フォーマット: neat
• 保管温度: 2-8°C
• SMILES記法: Cl.C1CN=C(CN(Cc2ccccc2)c3ccccc3)N1
• InChI: 1S/C17H19N3.ClH/c1-3-7-15(8-4-1)13-20(14-17-18-11-12-19-17)16-9-5-2-6-10-16;/h1-10H,11-14H2,(H,18,19);1H
• InChI Key: SWKDMSRRIBZZAY-UHFFFAOYSA-N
• 遺伝子情報: human ... HRH1(3269)

詳細

詳細

This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia.For further information and support please go to the website of the issuing Pharmacopoeia.

アプリケーション

Antazoline hydrochloride EP Reference standard, intended for use in laboratory tests only as specifically prescribed in the European Pharmacopoeia.

生物化学的／生理学的作用

Imidazoline agonist; H₁ histamine receptor antagonist.

Imidazoline agonist; more potent than efaroxan in inducing insulin release from β cells; H₁ histamine receptor antagonist.

包装

この製品は発行元の薬局方による供給としてお届けします。現在の単位量については、EDQM reference substance catalogueをご覧ください。

その他情報

Sales restrictions may apply.

安全性情報

• ピクトグラム: GHS07
• シグナルワード: Warning
• 危険有害性情報: H302 + H312 + H332,H315,H319,H335
• 注意書き: P261 - P280 - P301 + P312 - P302 + P352 + P312 - P304 + P340 + P312 - P305 + P351 + P338
• 危険有害性の分類: Acute Tox. 4 Dermal - Acute Tox. 4 Inhalation - Acute Tox. 4 Oral - Eye Irrit. 2 - Skin Irrit. 2 - STOT SE 3
• ターゲットの組織: Respiratory system
• 保管分類コード: 11 - Combustible Solids
• WGK: WGK 3
• 引火点(°F): Not applicable
• 引火点(℃): Not applicable